Skip to main content
Year archive

Equasens — 2023 filings

All 30 regulatory filings released by Equasens (EQS) in 2023, sourced directly from the official regulator.

30 Filings
2023 Period
2023 filings (30)
Filing Released Lang
EQUASENS : Evolution du Comité de Direction du Groupe Equasens
Board/Management Information
2023-12-27 French
Equasens: Changes in the Equasens Group Executive Committee
Board/Management Information
2023-12-27 English
EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany
M&A Activity
2023-11-23 English
EQUASENS : Acquisition de l’allemand ADV et naissance de PHARMAGEST Germany
M&A Activity
2023-11-23 French
EQUASENS : Chiffre d’affaires du 3ème trimestre 2023
Earnings Release Q3 2023
2023-11-09 French
Equasens: Q3 2023 revenue
Earnings Release Q3 2023
2023-11-09 English
EQUASENS : Mise à disposition du Rapport Financier Semestriel 2023
Report Publication Announcement
2023-10-04 French
EQUASENS : Rapport financier Semestriel 2023
Interim / Quarterly Report H2 2023
2023-10-04 French
EQUASENS : Résultats Semestriels 2023
Earnings Release H1 2023
2023-09-29 French
EQUASENS: H1 2023 Results
Earnings Release H1 2023
2023-09-29 English
EQUASENS : bilan du contrat de liquidité au 30 juin 2023
Capital/Financing Update
2023-09-25 French
EQUASENS GROUP: H1 2023 revenue: up 9% to €112.62m
Earnings Release H1 2023
2023-08-03 English
GROUPE EQUASENS : Chiffre d’affaires du 1er semestre 2023 en progression de 9 % à 112,62 M€
Earnings Release H1 2023
2023-08-03 French
EQUASENS : résultat du vote des résolutions présentées à l’assemblée générale ordinaire annuelle du 29 juin 2023
Declaration of Voting Results & Voting Rights Announcements
2023-07-05 French
EQUASENS: results of the votes on the resolutions submitted to the ordinary annual shareholders' meeting of 29 june 2023
Declaration of Voting Results & Voting Rights Announcements
2023-07-05 English
EQUASENS : ASSEMBLEE GENERALE ORDINAIRE ANNUELLE - AVIS DE CONVOCATION - MISE EN LIGNE DES DOCUMENTS PREPARATOIRES
AGM Information
2023-06-09 French
EQUASENS: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS
AGM Information
2023-06-09 English
EQUASENS : Chiffre d’affaires T1 2023 : +13,96% à 56,25 M€
Earnings Release Q1 2023
2023-05-11 French
EQUASENS: Q1 2023 revenue: +13.96% to €56.25m
Earnings Release Q1 2023
2023-05-11 English
EQUASENS : Mise à disposition du Document d’Enregistrement Universel 2022
Report Publication Announcement
2023-05-04 French
DOCUMENT D'ENREGISTREMENT UN IVERSEL 2022
Annual Report (ESEF) FY 2022
2023-04-28 French
DOCUMENT D'ENREGISTREMENT UN IVERSEL 2022
Annual Report (ESEF) FY 2022
2023-04-28 French
EQUASENS : Atoopharm, le spécialiste e-learning de la formation officinale, rejoint le Groupe Equasens.
M&A Activity
2023-04-06 French
EQUASENS : Acquisitions de Pratilog et Speech2Sense
M&A Activity
2023-04-03 French
EQUASENS : Résultat Net 2022 : +18,35% à 48,70 M€
Earnings Release FY 2022
2023-03-24 French
EQUASENS: 2022 Net Profit: +18.35% to €48.70m
Earnings Release FY 2022
2023-03-24 English
EQUASENS : CA 2022 : +10,88% à 214,07 M€
Earnings Release FY 2022
2023-02-03 French
EQUASENS: FY 2022 revenue: +10.88% to €214.07m
Earnings Release FY 2022
2023-02-03 English
EQUASENS : BILAN SEMESTRIEL S2-2022 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC GILBERT DUPONT
Transaction in Own Shares
2023-01-20 French
EQUASENS: H2 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH GILBERT DUPONT
Share Issue/Capital Change
2023-01-20 English